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During a 3-year study period in a university teaching hospital, 417 nosocomial
infections associated with Pseudomonas aeruginosa were documented in 321
patients. The overall rate of P. aeruginosa nosocomial infection was 5.3 cases per
1,000 patients. Residence on the surgery or medicine service, advanced patient
age, and exposure to the burn, surgery, or medicine intensive care units correlated
with higher rates of infection. The most common sites for P. aeruginosa infection
were the lower respiratory tract, urinary tract, blood stream, and surgical
wounds. Nosocomial P. aeruginosa lower respiratory tract and blood stream
infections were significantly associated with exposure to certain intensive care
units, whereas P. aeruginosa urinary tract infections more commonly occurred on
the neurology and neurosurgery services. Results of live antigen serotyping
showed that serotype 6 was most common, followed by serotypes 1 and 11.
Serotype 6 correlated with resistance to carbenicillin, gentamicin, and tobramy-
cin, and serotype 11 correlated with resistance to carbenicillin. Two-thirds of the
isolates tested were sensitive to carbenicillin, gentamicin, and tobramycin, but
13.2% were resistant to all three of these drugs. P. aeruginosa isolates resistant to
all three drugs were associated with urinary tract infections.
In recent decades, Pseudomonas aeruginosa
has emerged as an important nosocomial patho-
gen. According to data accumulated by the
Comprehensive Hospital Infections Project, P.
aeruginosa strains accounted for approximately
11% of all pathogens recovered from nosocomial
infections (3). Hospital-acquired infections
caused by this organism are often associated
with high morbidity and mortality rates. Exam-
ples are pseudomonal bacteremia (35 to 50%
mortality) and pseudomonal pneumonia (70 to
90% mortality) (10, 11, 13).
Although several published studies (1, 3-5)
have presented overviews or specific aspects of
the epidemiology of hospital-acquired infections
caused by P. aeruginosa, a detailed epidemio-
logical description for a particular hospital set-
ting is lacking. Therefore, we undertook a study
of P. aeruginosa-associated nosocomial infec-
tions at our institution. During a 3-year period,
321 patients developed a total of 417 hospital-
acquired infections from which P. aeruginosa
was recovered. Serotyping and antibiotic sensi-
tivity tests were performed on 86% of the iso-
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lates. An analysis of these and other epidemio-
logical data are the subject of this report.
MATERIALS AND METHODS
The study was conducted from December 1976 to
December 1979 at the North Carolina Memorial Hos-
pital, a 640-bed teaching hospital for the University of
North Carolina School of Medicine. Nosocomial infec-
tion surveillance was done by two full-time infection
control practitioners who used criteria established by
the Centers for Disease Control for defining nosocomi-
al infections (7). In all cases, the infections were not
believed to be either present or incubating at the time
of admission, and in no instance was the patient
considered to be simply colonized with the organism.
Signs of active infection were present in every case.
Patients with asymptomatic bacteriuria were not re-
corded as having a urinary tract infection.
The hospital infection control files were examined
for each patient with a nosocomial infection from
which P. aeruginosa was recovered during the study
period. The following data were recorded: patient age,
sex, and race, hospital service (medicine, surgery,
etc.), admission date, ward location, intensive care
unit (ICU) stay before infection, the date that P.
aeruginosa was isolated, the infection site, and the
antibiogram and serotype of the organism. Each iso-
late of P. aeruginosa was recovered from a specific
infection site. For example, among nosocomial pneu-
monias, the organism was cultured from purulent
sputum obtained from a patient with a persistently
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abnormal chest radiograph (parenchymal infiltrate)
and fever. In many cases, evidence for infection was
found on the gram-stained sputum samples. When the
organism was recovered from a particular site on
several occasions, it was counted only once. The
frequency of recovery of other bacteria from noso-
comial infections which occurred during the study
period was also noted.
Antimicrobial sensitivity testing was performed in
the clinical microbiology laboratory of the hospital by
the Kirby-Bauer disk method (2).
Serotyping (O antigen) was carried out in the hospi-
tal epidemiology laboratory by the live-antigen method
of Brokopp et al. (6) with two exceptions: (i) antisera
pools were not used, and (ii) organisms initially found
to be nontypable were incubated overnight in tryptic
soy broth. The culture was then boiled for 15 min and
centrifuged, and the pellet was suspended in 10 ml of
sterile saline. This preparation was then used in the
live-antigen testing procedure.
Rates of infection were calculated from the number
of cases per 1,000 admissions. Statistical analysis was
done by the chi-square test, with Yates correction as
needed, or by Fisher's exact test.
RESULTS
During the 3-year study period, P. aeruginosa
was recovered from 417 documented nosocomi-
al infections in 321 patients. Overall, it was
found in 12.5% of all hospital-acquired infec-
tions in that period, behind Escherichia coli
(13.2%) and ahead of Staphylococcus aureus
(10.5%) infections. Based upon comparisons of
antibiogram and serotype patterns, there was
very little evidence for cross-infection with P.
aeruginosa during the study period, and no
significant outbreak of infections caused by this
organism was documented during the 3-year
period.
The overall rate of nosocomial P. aeruginosa
infections was 5.3 cases per 1,000 patient admis-
sions. The low rate was 1.4 cases per 1,000
admissions in the 11 to 20 age group, and the
high was 13.7 cases per 1,000 admissions in the
71 to 80 age group (Fig. 1). The majority of
infections (60%) occurred in patients between 50
and 80 years of age. Case breakdown by race
revealed 63% of the patients were white and 37%
were nonwhite. This closely paralleled the hos-
pital's overall admissions statistics for race (62%
white and 38% nonwhite). Males accounted for
57% of all cases and represented 43% of the total
patient population admitted during the study
period. The surgery service accounted for 55%
of the cases and the medicine, pediatric, and
obstetrics and gynecology services accounted
for 36, 5, and 4% of the cases, respectively.
Rates of infection by service were as follows
(per 1,000 admissions): surgery, 10 cases; medi-
cine, 5 cases, and 1 case each for both pediatrics
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FIG. 1. Age-related rate of occurrence for noso-
comial infections associated with P. aeruginosa.
The rate of nosocomial P. aeruginosa infec-
tions was strongly related to patient exposure to
an ICU. The rate was 41 cases per 1,000 admis-
sions for patients who stayed in an ICU, com-
pared with 2 cases per 1,000 admissions for
patients who were never exposed to an ICU
(Table 1). The high rate was 130 cases per 1,000
admissions in the burn ICU, and the low was 3
cases per 1,000 admissions in the coronary ICU.
A total of 506 patients developed nosocomial
infections while hospitalized in an ICU during
the study period, and 180 (35.6%) developed
TABLE 1. Rates of nosocomial P. aeruginosa
infection in various ICUs
No. of Rate of infection
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TABLE 2. Infection sites associated with P.
aeruginosa isolates
Nof FrequencyInfection site No. of (% ofisolates total)
Lower respiratory tract 130 31.1
Urinary tract 122 29.3
Bloodstream 62 14.8
Surgical wound 59 14.1
Burn wound 14 3.3
Nonsurgical skin 7 1.7
Ear and sinus 7 1.7
Eye 5 1.2
Vascular catheter 3 0.7
Central nervous system 3 0.7
Abdomen 2 0.5
Other 3 0.7
infections from which P. aeruginosa was recov-
ered. Nosocomial infections associated with P.
aeruginosa were uncommon in the premature
infant nursery (neonatal ICU); the rate of infec-
tion was 1.4 cases per 1,000 admissions during
the study period.
The lower respiratory tract, urinary tract,
bloodstream, and surgical wound sites were the
source of 90% of the nosocomial P. aeruginosa
isolates (Table 2). The majority (75%) of the
lower respiratory tract infections were pneumo-
nias. Of the bacteremias, 88% were believed to
be secondary to P. aeruginosa infections at
other sites, and 80% of the wound infections
were judged to be skin infections at operative
sites. During the study period, the overall rate of
nosocomial surgical wound infections was 20.8
per 1,000 operative procedures, and the rate of
wound infections associated with P. aeruginosa
was 2.3 per 1,000 operative procedures. The
four most common sites of P. aeruginosa infec-
tion and the rate of occurrence per 1,000 admis-
sions were: lower respiratory tract, 2.1 cases;
urinary tract, 1.9 cases; bloodstream, 1.0 cases;
and surgical wounds, 0.9 cases. The occurence
rates for these sites were 22.9, 12.9, 8.7, and
6.6%, respectively, for patients exposed to an
ICU. Further analysis of these data revealed
that the occurrence of nosocomial P. aeruginosa
lower respiratory tract infections was signifi-
cantly related to exposure to the medicine (P <
0.001) and surgery (P < 0.01) ICUs and that
nosocomial P. aeruginosa bloodstream infec-
tions were associated with exposure to the medi-
cine ICU (P < 0.02). Nosocomial P. aeruginosa
urinary tract infections were associated with
residence on the neurology or neurosurgery
services (P < 0.01).
P. aeruginosa was the second most common
nosocomial pathogen found in the respiratory
tract, urinary tract, and bloodstream and the
fourth most common in surgical wounds. It
ranked behind S. aureus as a cause of nosocomi-
al infection in the respiratory tract and behind E.
coli as a cause of nosocomial infection in the
urinary tract and bloodstream.
Serotype 6 was the most commonly docu-
mented (20.7% of all isolates), and serotypes 1,
6, 10, and 11 accounted for 65% of the isolates
tested (Table 3). There was a limited number of
nontypable isolates (7.0%), and isolates with
multiple serotype patterns (agglutinated in more
than one antiserum) were infrequent (4.8%). The
majority of the isolates tested (64.2%) were
sensitive to carbenicillin (Cs), gentamicin (G5),
and tobramycin (T5), but 13.2% were resistant to
all three of these antibiotics (CGTr). This latter
drug resistance pattern was statistically related
to recovery of the organism from the urinary
tract (P < 0.005). However, no relationship
between drug resistance and patient exposure to
an ICU was found. There was a statistically
significant relationship between antibiotic sensi-
tivity pattern Cr GS T' and serotype 11 (P < 0.01)
and between sensitivity pattern CGTr and sero-
type 6 (P < 0.001). Three serotype 11 strains
with the Cr GS T' sensitivity pattern were recov-
ered from the bloodstream, three from the uri-
nary tract, two from the respiratory tract, and
one each from spinal fluid, eye, and pleural fluid
samples. Twelve serotype 6 organisms with the
CGTr sensitivity pattern were recovered from
the urinary tract, four from the respiratory tract,
three from surgical wounds, two from the blood-
stream, and one each from spinal fluid, eye, and
skin samples.
Serotype data were available for 333 of the 374
P. aeruginosa isolates obtained from the four
major sites, and no significant association be-
tween serotype and infection site was found
(Table 4). Likewise, no correlation between
serotype and hospital service or location in the
hospital was noted.
DISCUSSION
P. aeruginosa is a well-recognized nosocomial
pathogen that can cause severe infections in
hospitalized patients. Interestingly, little has
been written on the epidemiology of this orga-
nism in specific hospital settings. Therefore, we
studied the epidemiology of 417 nosocomial P.
aeruginosa infections documented in 321 pa-
tients over a 3-year period. We found that P.
aeruginosa was associated with 12.5% of all
nosocomial infections during the study period.
This percentage is similar to the -10% figure
reported by Bennett (3), whose data reflected
the experience of community hospitals in the
Comprehensive Hospital Infections Project. The
overall rate of P. aeruginosa infection (5.3 cases
per 1,000 admissions) documented in our study
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TABLE 3. Serotype and sensitivity data for 356 nosocomial P. aeruginosa isolates
No. of isolates (%) that were serotype:a Total no. (%) of
Sensitivity ioae hwnpattern 1 3 4 5 6 8 9 10 11 16 NT MT Other isolates showing
(16.8) (7.0) (3.9) (5.0) (20.7) (2.2) (2.0) (10.6) (16.8) (2.2) (7.0) (4.8) (1.1) sensitivity pattern
CGTS 47 19 7 16 37 5 5 23 34 6 15 13 3 230 (64.2)
Cb GS TS 2 1 0 0 6 0 0 5 1 1 2 1 1 20 (5.6)
C GSTS 5 3 0 1 4 0 1 1 11 1 0 0 0 27 (7.5)
CS Gr Tr 0 1 0 0 0 0 0 3 4 0 1 0 0 9 (2.5)
Cr Gr Tr 0 0 7 0 24 0 0 5 3 0 6 2 0 47 (13.2)
Other 6 1 0 1 3 3 1 1 7 0 1 1 0 25 (7.0)
a NT, Nontypable; MT, multiple serotype.
b Indeterminate sensitivity.
and the particular occurrence of these infections
in older patients (Fig. 1) also agreed with the
findings of Bennett (3). When compared with
data from the National Nosocomial Infections
Study hospitals (8), our overall rate for P. aeru-
ginosa infection was higher (5.3 versus 3.4 cases
per 1,000 admissions). The most notable differ-
ences were found in the rates for bloodstream
and lower respiratory tract infections; the rates
we found exceeded those reported by the Na-
tional Nosocomial Infections Study hospitals by
10- and 3.5-fold, respectively.
The vast majority of nosocomial P. aerugino-
sa infections (91%) were found on the surgical
and medical services (55 and 36%, respectively).
On a hospitalwide basis, the lower respiratory
tract and urinary tract represented the most
common sites of nosocomial P. aeruginosa in-
fection (Table 2), followed by the bloodstream
and surgical wounds.
TABLE 4. Serotype distribution of 333 isolates of
P. aeruginosa obtained from the four major sites
No. of isolates from infection site:
Serotype Respiratory Urinary Blood- Surgical
tract tract stream wound
1 14 22 13 7
2 1 0 0 0
3 10 6 3 6
4 5 6 2 0
5 8 8 1 1
6 22 19 14 10
7 0 1 0 0
8 1 1 1 1
9 2 1 2 2
10 11 11 10 4
11 21 13 12 9
14 0 0 0 1
15 0 0 0 1
16 4 3 1 0
NTa 11 7 3 3
MTb 8 6 0 4
a NT, Nontypable.
b MT, Multiple serotype.
Compared with the data in Bennett's report
(3), the rate of lower respiratory tract P. aeru-
ginosa infection documented in our study was
two times higher, and the rate of bloodstream
infection was five times higher. These differ-
ences may be partly explained by different pa-
tient populations. Our facility serves largely as a
tertiary-care referral center, whereas the Com-
prehensive Hospital Infections Project encom-
passed a community hospital population. We
probably have a larger proportion of patients
who require intensive support measures (respi-
ratory assistance, invasive monitoring, etc.)
than the community hospital does, and our pa-
tients may be more prone to developing certain
nosocomial P. aeruginosa infections. Similarly,
differences between our results and those of the
National Nosocomial Infections Study hospitals
are probably due to different patient popula-
tions. Approximately 70% of the National Noso-
comial Infections Study hospitals are catego-
rized as community or community-teaching
hospitals.
We found a rate of P. aeruginosa infection of
41 cases per 1,000 admissions for patients ex-
posed to an ICU, in marked contrast to the rate
of 2 cases per 1,000 admissions for patients not
so exposed. The type of ICU exposure was also
important, as 80% of the cases occurred in the
burn, surgery, and medicine ICUs (Table 1).
There was a significant correlation between the
occurrence of nosocomial lower respiratory
tract P. aeruginosa infection and exposure to
the medicine or surgery ICU. P. aeruginosa
bloodstream infections also were significantly
related to exposure to the medicine ICU. Com-
pared with the other ICUs at our hospital, the
burn, surgery, and medicine ICUs generally
provide care to sicker patients with multiple
underlying illnesses and host defense deficien-
cies and to those who require a variety of
invasive monitoring and support devices. An
interesting contrast was seen in the coronary
ICU, where the rate of nosocomial P. aerugino-
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sa infection was essentially the same as that for
persons without any ICU exposure.
Serotype data generated by our study showed
that serotypes 1, 6, and 11 were the most com-
monly identified and that serotype 6 was recov-
ered most often (Table 3). This finding is consist-
ent with that reported by Brokopp et al. (6), who
serotyped P. aeruginosa isolates supplied by six
different hospitals. We also describe a statisti-
cally significant association between certain se-
rotypes and particular antibiotic sensitivity pat-
terns. Serotype 6 was associated with resistance
to carbenicillin, gentamicin, and tobramycin,
and serotype 11 was associated with resistance
to carbenicillin. An association between particu-
lar serotypes and sensitivity patterns is not
unique and has been reported by others (12). In
contrast, there was no significant association
between serotype and site of infection, service,
or location in the hospital. Interestingly, the
association between nosocomial P. aeruginosa
urinary tract infections and patient residence on
the neurology or neurosurgery service did not
also involve an association between a particular
sensitivity pattern or serotype. Our inability to
document correlations in these areas might be
due to the few instances of suspected cross-
infection during the study period. It is conceiv-
able that we might have shown a clustering of a
particular serotype, as recently suggested by
Farmer et al. (9), if more significant outbreaks of
P. aeruginosa infection had occurred during the
period.
Antibiotic sensitivity testing showed that
nearly two-thirds of the isolates were suscepti-
ble to carbenicillin, gentamicin, and tobramycin,
but 13.2% were resistant to all three antibiotics.
There was no association between the recovery
of resistant isolates and patient exposure to an
ICU, but the association between recovery of
isolates resistant to all three drugs and urinary
tract infection was significant.
In summary, we found that P. aeruginosa was
the second most common pathogen isolated
from nosocomial infections at our hospital. It
was particularly likely to be recovered from
elderly patients exposed to the burn, surgery, or
medicine ICU, for which the rate of lower
respiratory tract P. aeruginosa infections was
high. The recovery of isolates resistant to car-
benicillin, gentamicin, and tobramycin was rela-
tively limited and was particularly associated
with urinary tract infections. Serotyping proved
to be an important tool in our assessment of
suspected P. aeruginosa outbreaks.
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